Group 1: Profit Forecasts - Dongcai Technology expects a net profit of approximately 300 million yuan for 2025, representing a year-on-year increase of about 65.73% [1] - Aerospace Electronics anticipates a net profit of 192 million to 247 million yuan for 2025, a decrease of 55% to 65% year-on-year [2] - Oulai New Materials forecasts a loss of 33 million to 48 million yuan for 2025, compared to a profit of 28.17 million yuan in the previous year [3] - Jiu Ding New Materials projects a net profit of 85 million to 98 million yuan for 2025, reflecting a year-on-year increase of 187.68% to 231.68% [5] - Chuan Yi Technology expects a net profit of 78 million to 103 million yuan for 2025, reversing a loss of 73.47 million yuan from the previous year [6] - Ju Yi Technology anticipates a net profit of 70 million to 105 million yuan for 2025, representing a year-on-year increase of 228.36% to 392.54% [7] - ST Xifa forecasts a net profit of 110 million to 160 million yuan for 2025, a year-on-year increase of 319.91% to 510.77% [19] - Light Media expects a net profit of approximately 1.5 billion to 1.9 billion yuan for 2025, reflecting a year-on-year increase of 413.67% to 550.65% [34] - Tianqi Lithium anticipates a profit of 369 million to 553 million yuan for 2025, compared to a loss of 7.905 billion yuan in the previous year [31] Group 2: Loss Forecasts - Star Ring Technology expects a loss of 220 million to 250 million yuan for 2025, with a projected revenue of 420 million to 450 million yuan, a year-on-year increase of 13.06% to 21.13% [9] - Filinger anticipates a loss of 65 million to 85 million yuan for 2025, compared to a loss of 37.31 million yuan in the previous year [10] - Jiahe Meikang forecasts a loss of 240 million to 280 million yuan for 2025, compared to a loss of 256 million yuan in the previous year [11] - Light Textile City expects a loss of 15 million to 22.5 million yuan for 2025 [23] - Ailon Technology anticipates a profit of 14.96 million to 22.44 million yuan for 2025, reversing a loss of 21.70 million yuan from the previous year [24] - ST Yun Chuang forecasts a loss of 139 million to 149 million yuan for 2025, with projected revenue of 53.5 million to 57.5 million yuan, a year-on-year increase of 6.15% to 14.09% [42] - Meike Home expects a loss of 1.2 billion to 1.8 billion yuan for 2025, compared to a loss of 864 million yuan in the previous year [36] Group 3: Shareholder Actions - Huafeng Chemical announced that shareholders plan to reduce their holdings by no more than 0.73% of the company's shares [8] - Naxinwei disclosed that shareholders plan to reduce their holdings by no more than 1.75% of the company's shares [12] - Shikong Technology announced that a shareholder plans to reduce their holdings by no more than 3% of the company's shares [13] - Yandong Micro disclosed that a shareholder plans to reduce their holdings by no more than 1% of the company's shares [37] - Daily Interaction announced that shareholders plan to reduce their holdings by no more than 0.135% of the company's shares [41]

Performance Forecast - The company expects a net loss attributable to shareholders of the parent company for the year 2025 to be between RMB -280 million and -240 million [3] - The expected net profit attributable to shareholders of the parent company, after deducting non-recurring gains and losses, is projected to be between RMB -286 million and -246 million [3] Previous Year Performance - In the previous year (2024), the total profit was RMB -229.82 million, with a net loss attributable to shareholders of the parent company of RMB -256.12 million [5] - The net profit attributable to shareholders of the parent company, after deducting non-recurring gains and losses, was RMB -261.38 million [5] - The earnings per share for the previous year were RMB -1.86 [6] Reasons for Performance Changes - The decline in revenue is attributed to reduced or delayed fiscal budget support from local governments for public hospitals' medical information construction, leading to compressed or postponed procurement demands [7] - Additionally, the implementation of medical insurance cost control reforms has resulted in decreased income for some hospitals, further compressing the demand for medical information construction funded by their own resources [7] - The company has increased investment in product development for data and artificial intelligence business opportunities, contributing to the reported losses [7]

Group 1 - The company Jiahe Meikang expects a net profit attributable to shareholders of the parent company to be between -280 million RMB and -240 million RMB for the year 2025, indicating a loss [1] - The primary reason for the performance change is the reduction or delay in fiscal budget support from local governments for public hospitals' medical information construction due to overall economic cycle fluctuations, leading to compressed or postponed procurement demands from hospitals [1] - Additionally, after the full implementation of medical insurance cost control reforms, some hospitals experienced reduced income, which further compressed the demand for medical information construction funded by their own resources, resulting in a further decline in the company's revenue [1] Group 2 - The news also highlights a crisis involving the "Jie Wo Rui" platform under Shuibei Gold, where a 40-fold leverage bet has led to losses as gold prices rise, with investors expressing dissatisfaction over a proposed repayment plan that offers only 20% of the principal [1]

2025 年年度业绩预告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、本期业绩预告情况 证券代码：688246 证券简称：嘉和美康 公告编号：2026-003 嘉和美康（北京）科技股份有限公司 （二）每股收益：-1.86 元。 三、本期业绩变化的主要原因 （一）业绩预告期间 2025 年 1 月 1 日至 2025 年 12 月 31 日。 （二）业绩预告情况 （1）经嘉和美康（北京）科技股份有限公司（以下简称"公司"）财务部 门初步测算，预计 2025 年年度实现归属于母公司所有者的净利润将出现亏损， 实现归属于母公司所有者的净利润为人民币-28,000 万元至-24,000 万元。 （2）预计 2025 年度归属于母公司所有者的扣除非经常性损益的净利润为人 民币-28,600 万元至-24,600 万元。 （三）本次业绩预告未经注册会计师审计。 二、上年同期业绩情况和财务状况 （一）利润总额：-22,981.87 万元。2024 年度实现归属于母公司所有者的 净利润：-25,611.74 万元。2024 年度实 ...

格隆汇1月29日丨嘉和美康(688246.SH)公布，经公司财务部门初步测算，预计2025年年度实现归属于母 公司所有者的净利润将出现亏损，实现归属于母公司所有者的净利润为人民币-2.8亿元至-2.4亿元。预 计2025年度归属于母公司所有者的扣除非经常性损益的净利润为人民币-2.86亿元至-2.46亿元。 报告期内，受整体经济周期波动影响，地方财政给予公立医院进行医疗信息化建设的财政预算支持减少 或延迟到位，导致部分医院采购需求被压缩或延后；此外，部分医院在全面执行医保控费改革后收入减 少，利用自有资金进行的医疗信息化建设需求被压缩，导致公司收入进一步下滑。同时，面向"十五 五"人工智能应用市场机会，公司在 2025 年加大了对数据和人工智能业务的产品开发投入，导致报告期 内亏损。 ...

南财智讯1月29日电，嘉和美康发布年度业绩预告，预计2025年全年归属于上市公司股东的净利润 为-2.40亿元至-2.80亿元；预计2025年全年归属于上市公司股东的扣除非经常性损益的净利润为-2.46亿 元至-2.86亿元。报告期内，受整体经济周期波动影响，地方财政给予公立医院进行医疗信息化建设的 财政预算支持减少或延迟到位，导致部分医院采购需求被压缩或延后；此外，部分医院在全面执行医保 控费改革后收入减少，利用自有资金进行的医疗信息化建设需求被压缩，导致公司收入进一步下滑。同 时，面向"十五五"人工智能应用市场机会，公司在2025年加大了对数据和人工智能业务的产品开发投 入，导致报告期内亏损。 ...

Group 1 - The core viewpoint of the news is that 嘉和美康 experienced a decline in stock price and significant changes in financing and shareholder structure, indicating potential challenges in its financial performance and market position [1][2]. Group 2 - On January 22, 嘉和美康's stock price fell by 1.56%, with a trading volume of 190 million yuan. The financing data showed a net buying of 2.39 million yuan, with a total financing balance of 219 million yuan, which is 5.88% of its market capitalization [1]. - The company’s financing balance is at a high level, exceeding the 90th percentile of the past year, indicating increased reliance on financing [1]. - 嘉和美康's main business revenue composition includes software development and technical services (42.39%), self-developed software sales (37.64%), and sales of purchased software and hardware (19.86%) [1]. Group 3 - As of December 10, 嘉和美康 had 8,282 shareholders, a decrease of 5.61%, while the average circulating shares per person increased by 5.94% [2]. - For the period from January to September 2025, 嘉和美康 reported a revenue of 330 million yuan, a year-on-year decrease of 30.67%, and a net profit attributable to shareholders of -174 million yuan, a significant decline of 320.68% [2]. - Among the top ten circulating shareholders, 长城消费增值混合A reduced its holdings by 410,000 shares, while 易方达新常态混合 exited the top ten list [2].

Economic Information - Several smartphone manufacturers, including Xiaomi, OPPO, vivo, and Transsion, have lowered their annual shipment forecasts, with Xiaomi and OPPO reducing by over 20%, vivo by nearly 15%, and Transsion to below 70 million units [2] - Silver prices have surged over 50% in one month and over 150% in six months, impacting the photovoltaic industry, which consumes a significant amount of silver. The cost of raw materials for solar cells has increased by nearly 20% due to rising silver prices [2] - The company Xibei is expected to incur cumulative losses exceeding 600 million yuan from September 2025 to March 2026, leading to the closure of 102 stores, accounting for 30% of its total outlets [2] Company Alerts - Shenghong Technology anticipates a net profit increase of 260%-295% year-on-year for 2025, although Q4 performance fell short of expectations [4] - Cambridge Technology expects a net profit increase of 51%-67% year-on-year for 2025, with Q4 results also below expectations [4] - Multiple companies, including Weimait and Youyan Silicon, have announced plans to reduce their shareholdings by up to 4.98% and 3% respectively [4][11] Overseas Alerts - The three major U.S. stock indices collectively declined last Friday, with the Nasdaq China Golden Dragon Index dropping by 1.15%. Notable declines were seen in Chinese stocks such as Alibaba and JD.com [5] - The European Union is considering imposing tariffs on U.S. goods worth 93 billion euros in response to U.S. tariffs on eight European countries, which could take effect on February 6 if no agreement is reached [5]

证券代码：688246 证券简称：嘉和美康 公告编号：2026-002 嘉和美康（北京）科技股份有限公司 截至本公告披露日，嘉和美康（北京）科技股份有限公司（以下简称"嘉和 美康"或"公司"）股东弘云久康数据技术（北京）有限公司（以下简称"弘云 久康"）持有公司股份 8,485,931 股，占公司股份总数的 6.17%。上述股份为嘉 和美康首次公开发行并上市前取得的股份，且已于 2022 年 12 月 14 日起上市流 通。 减持计划的主要内容 公司于 2026 年 1 月 15 日收到弘云久康出具的《关于弘云久康数据技术（北 京）有限公司减持计划的告知函》，因自身流动性需求，股东弘云久康计划自 2026 年 2 月 9 日起 3 个月内根据市场情况通过集中竞价方式减持其持有的公司股份合 计不超过 1,375,855 股，即不超过公司总股本的 1%。 | 股东名称 | 弘云久康数据技术（北京）有限公司 | | | --- | --- | --- | | 股东身份 | 控股股东、实控人及一致行动人 | □是√否 | | | 直接持股 5%以上股东 | √是□否 | | | 董事、监事和高级管理人员 | □是√否 ...

格隆汇1月16日丨嘉和美康(688246.SH)公布，公司于2026年1月15日收到弘云久康出具的《关于弘云久 康数据技术（北京）有限公司减持计划的告知函》，因自身流动性需求，股东弘云久康计划自2026年2 月9日起3个月内根据市场情况通过集中竞价方式减持其持有的公司股份合计不超过137.59万股，即不超 过公司总股本的1%。 ...